GLP-1 Receptor Agonists Reduce All-Cause Mortality and Non-Fatal Myocardial Infarction in Overweight and Obese Adults Without Diabetes Mellitus: Results of a Systematic Review and Meta-Analysis - 08/08/25
Doi : 10.1016/j.hlc.2025.06.872
W. Yao 1, S. Sathiyapal 2, R. Machado 1, A. Amarasekera 2, 3, T. Tan 1, 2, 4
1 Department of Cardiology, Blacktown Hospital, Blacktown, NSW, Australia
2 Department of Cardiology, Westmead Hospital, Westmead, NSW, Australia
3 Westmead Heart Rhythm Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
4 School of Medicine, Western Sydney University, Sydney, NSW, Australia
856
Il testo completo di questo articolo è disponibile in PDF.Mappa
© 2025
Pubblicato da Elsevier Masson SAS.
Vol 34 - N° S4
P. S645-S646 - agosto 2025 Ritorno al numero
Articolo precedente
- Frailty Risk After a Cardiovascular Event Among Community-Dwelling Older People: Influence of Sociodemographic, Polypharmacy and Pre-Event Frailty Status
- A. Phyo, A. Tonkin, S. Espinoza, A. Ekram, R. Woods, J. Ryan
- Haptoglobin Phenotype and Cardiovascular Disease: A Systematic Review and Meta-Analysis
- W. Tucker, K Leung Ong, A. Januszewsk, A. Keech
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?